SEC
RXDX

Seven Eight Capital’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Seven Eight Capital’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,627
Closed -$1.39M – 644
2022
Q4 		$1.39M Buy
+12,627
New +$1.39M 0.36% 84